Zealand’s ‘aspirational’ mission for its amylin drug to be first-line in obesity

A few years ago, government agencies were debating how to handle kratom, a substance made from the leaves of a Southeast Asian tree, which was

As­traZeneca’s asth­ma treat­ment Fasen­ra will now be avail­able to younger pa­tients, height­en­ing the com­pe­ti­tion in a crowd­ed field of res­pi­ra­to­ry ri­vals. The FDA has ex­pand­ed